Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States. The company's lead molecule is rose bengal sodium, a class of bioactive synthetic small molecules halogenated xanthenes. Its clinical...
6 insider purchases on record · latest filing 2017-12-18.
Insiders have also filed 50 sale transactions at PVCT.